HomeSearchMediterranean Journal of Hematology and Infectious Diseases

Mediterranean Journal of Hematology and Infectious Diseases

Universita Cattolica del Sacro Cuore · Italy · Est. 1874

ISSN2035-3006eISSN2035-3006
SJR Q3WOS SCIEScopus / SJRDOAJOpen Access
62
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q3+12
DOAJ Verified+15
Total62
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
0.461
H-Index
58
CiteScore
3.3
SNIP
0.62
Total Works
1,205
Total Citations
18,793
2yr Mean Citedness
1.25
Free JIF alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

The Mediterranean Journal of Hematology and Infectious Diseases publishes original articles and topical reviews concerning both clinical hematology and infectious diseases. A particular attention will be deserved to original article focusing on the relationship between blood and infectious diseases. Reciprocal interdependence between infectious and hematologic diseases (malignant and non-malignant) is well known. This relationship is particularly evident in Mediterranean countries. Parasitosis such as Malaria, Leishmaniosis, B Hookworms, and Teniasis, very common in the southeast Mediterranean area, infects about a billion people and manifest prevalently with anemia so they are usually diagnosed mostly by experienced hematologists on blood or bone marrow smear. On the other hand, infections are also a significant problem in patients affected by hematological malignancies. The blood is the primary vector of HIV infection, which otherwise manifests with symptoms related to a reduction in T lymphocytes. In turn, infections can favor the insurgency of hematological malignancies. The causative relationship between Epstein-Barr virus infection, Helicobacter pylori , hepatitis C virus, HIV, and lymphoproliferative diseases is well known. Editorials from editors (specialists in hematology and infectious diseases) or comments will be welcomed to highlight particularly relevant articles that appeared in this journal or in the more prestigious international journals. MJHID will be a leading journal on subjects of current importance in clinical hematology and infectious diseases. Every issue would have, besides the Editor in chief, a guest editor. Both editors invite experts on the selected topic to perform a complete update of the arguments readily available for practicing physicians. The journal will also have a section devoted to original papers, which will be distinguished in Full articles, Scientific letters, Educational, Clinical cases, Case Reports, and Letters to the Editor. Publication of Case Reports is not a main scope of this Journal and will represent a limited number of papers published. They will be considered when they significantly expand the field of general medical knowledge and/or contribute to acknowledging the pathophysiology of the disease. The rarity of the disease is not considered a criterion of priority. Case reports of a puzzling diagnosis, well documented, and having a prevalent educational character will be assigned to the section MJHID Educational Clinical Case. A case report reported in fewer than 3 pages should be submitted as a Letter to the Editor. Case reports with the review of the literature should be structured similarly to review articles. Clinical trials of hematological and infectious diseases in the Mediterranean area will have their natural home in this Journal. Papers with translational research strictly correlated to clinical problems will also be considered.

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
12
weeks to review
Average · median is 15 wks
Q3
SJR Rank
Top 75% in field

General Information

Country / RegionItaly
Primary LanguageEnglish
1st Year Published1874
Frequencybimonthly
StatusActive (last: 2026)
Total Publications1,205
Publisher OrgPAGEPress (Italy)
OA Since2008
Visit Journal Website

Submission Info

Peer ReviewPeer review
Review Time~12 weeks
Acceptance Rate
OA LicenseCC BY-NC
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
LOCKSSPKP PN

Think.Check.Submit Compliance

10/12 · 83%
Do you know the journal / publisher?
Universita Cattolica del Sacro Cuore
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2035-3006 / 2035-3006
Indexed in a trusted database?
WoS, Scopus, DOAJ
Peer review process documented?
Peer review
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
LOCKSS, PKP PN
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ3
Infectious DiseasesQ3

Subject Classification

Web of Science Categories

HematologyInfectious Diseases

Scopus Categories

HematologyInfectious Diseases

Research Topics (OpenAlex)

Hemoglobinopathies and Related DisordersAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentIron Metabolism and DisordersChronic Lymphocytic Leukemia ResearchBlood groups and transfusionAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentNeutropenia and Cancer Infections
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref